Results 211 to 220 of about 1,007,541 (342)

Effects of intraoperative different fluid therapy protocols on postoperative renal functions. [PDF]

open access: yesBMC Anesthesiol
Dumanlı Özcan AT   +7 more
europepmc   +1 more source

Intravenous Fluid Therapy of Calves

open access: green, 1999
Joachim Berchtold
openalex   +1 more source

Normalization of Cerebrospinal Fluid Abnormalities after Neurosyphilis Therapy: Does HIV Status Matter? [PDF]

open access: bronze, 2004
Christina M. Marra   +11 more
openalex   +1 more source

The use of thrombolytics in the management of complex pleural fluid collections [PDF]

open access: yes, 2017
Bahjri, Khaled   +6 more
core   +2 more sources

In Vitro Modeling of Natural Killer Cell Cytotoxicity to Inform Personalized ALS Therapeutics

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Natural killer (NK) cells might contribute to motor neuron death in amyotrophic lateral sclerosis (ALS) through direct cytotoxicity, a process that could be inhibited with the FDA‐approved JAK/STAT pathway inhibitor, tofacitinib. This study aimed to verify that tofacitinib can suppress NK cell cytotoxicity, investigate if immune cell
Benjamin J. Murdock   +8 more
wiley   +1 more source

Increasing Cerebrospinal Fluid Chemokine Concentrations Despite Undetectable Cerebrospinal Fluid HIV RNA in HIV-1–Infected Patients Receiving Antiretroviral Therapy

open access: bronze, 2000
Elisabeth H. Gisolf   +7 more
openalex   +1 more source

Digital Activity Markers in Chronic Inflammatory Demyelinating Polyneuropathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the utility of smartwatch and smartphone‐based activity metrics for assessing disease severity and quality of life in patients with chronic inflammatory demyelinating polyneuropathy (CIDP). Methods In the electronic monitoring of disease activity in patients with CIDP (EMDA‐CIDP) trial, we performed a prospective ...
Lars Masanneck   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy